DA Davidson Upgrades Procter & Gamble (NYSE:PG) to Buy

DA Davidson upgraded shares of Procter & Gamble (NYSE:PG) from a neutral rating to a buy rating in a research report report published on Monday, Marketbeat Ratings reports. The firm currently has $209.00 target price on the stock, up from their previous target price of $160.00. DA Davidson also issued estimates for Procter & Gamble’s Q2 2025 earnings at $1.87 EPS, FY2025 earnings at $7.03 EPS and FY2026 earnings at $7.49 EPS.

Other equities research analysts have also issued reports about the company. JPMorgan Chase & Co. boosted their target price on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Wells Fargo & Company boosted their price objective on Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a report on Friday, November 22nd. Piper Sandler started coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price for the company. Evercore ISI upped their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. Finally, Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $180.45.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $179.36 on Monday. The stock has a market cap of $422.40 billion, a price-to-earnings ratio of 30.92, a PEG ratio of 3.82 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. Procter & Gamble has a 12 month low of $142.50 and a 12 month high of $180.43. The stock’s 50 day moving average price is $170.37 and its 200 day moving average price is $168.98.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the previous year, the business earned $1.83 EPS. The company’s quarterly revenue was down .6% compared to the same quarter last year. Equities research analysts anticipate that Procter & Gamble will post 6.96 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.24%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio is 69.48%.

Insider Transactions at Procter & Gamble

In related news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the transaction, the insider now directly owns 11,595 shares in the company, valued at $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Susan Street Whaley sold 634 shares of the company’s stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares of the company’s stock, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 35,233 shares of company stock worth $6,024,234. Company insiders own 0.18% of the company’s stock.

Institutional Trading of Procter & Gamble

A number of institutional investors and hedge funds have recently modified their holdings of PG. Concurrent Investment Advisors LLC raised its stake in Procter & Gamble by 4.5% during the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after acquiring an additional 4,035 shares in the last quarter. Radnor Capital Management LLC acquired a new position in Procter & Gamble in the third quarter valued at about $5,705,000. Welch Group LLC grew its stake in Procter & Gamble by 0.9% during the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock worth $56,094,000 after buying an additional 2,990 shares during the last quarter. Swiss National Bank increased its holdings in shares of Procter & Gamble by 0.6% during the third quarter. Swiss National Bank now owns 7,005,790 shares of the company’s stock worth $1,213,403,000 after buying an additional 39,000 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Procter & Gamble by 67.2% in the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after acquiring an additional 10,777 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.